Filing Details
- Accession Number:
- 0001104659-25-034321
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-11 21:57:19
- Reporting Period:
- 2025-04-09
- Filing Date:
- 2025-04-11
- Accepted Time:
- 2025-04-11 21:57:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1664710 | Keros Therapeutics Inc. | KROS | Pharmaceutical Preparations (2834) | 811173868 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1758866 | Adar1 Partners, Lp | 3503 Wild Cherry Drive Building 9 Austin TX 78738 | No | No | Yes | No | |
1861120 | Daniel Schneeberger | 3503 Wild Cherry Drive Building 9 Austin TX 78738 | No | No | Yes | No | |
1940267 | Adar1 Capital Management Gp, Llc | 3503 Wild Cherry Drive Building 9 Austin TX 78738 | No | No | Yes | No | |
1940272 | Adar1 Capital Management, Llc | 3503 Wild Cherry Drive Building 9 Austin TX 78738 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-04-09 | 18,560 | $9.40 | 3,493,404 | No | 4 | P | Indirect | By ADAR1 Partners, LP |
Common Stock | Acquisiton | 2025-04-09 | 16,365 | $9.40 | 743,558 | No | 4 | P | Indirect | By Spearhead Insurance Solutions IDF, LLC |
Common Stock | Acquisiton | 2025-04-09 | 325,000 | $9.86 | 3,818,404 | Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Common Stock | Acquisiton | 2025-04-09 | 500,000 | $10.33 | 4,318,404 | Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Common Stock | Acquisiton | 2025-04-09 | 74,333 | $10.33 | 4,392,737 | Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | By ADAR1 Partners, LP |
No | 4 | P | Indirect | By Spearhead Insurance Solutions IDF, LLC |
Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Yes | 4 | P | Indirect | By ADAR1 Partners, LP |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Cash-Settled Total Return Swaps | Disposition | 2025-04-09 | 325,000 | $0.00 | 325,000 | $0.00 |
Common Stock | Cash-Settled Total Return Swaps | Disposition | 2025-04-09 | 500,000 | $0.00 | 500,000 | $0.00 |
Common Stock | Cash Settled Total Return Swaps | Disposition | 2025-04-09 | 74,333 | $0.00 | 74,333 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
624,333 | No | 4 | J | Indirect | ||
124,333 | No | 4 | J | Indirect | ||
50,000 | No | 4 | J | Indirect |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 254,669 | Indirect | By ADAR1 SPV I, LP |
Footnotes
- As the investment manager of ADAR1 Partners, LP and ADAR1 SPV I, LP and as the sub-advisor of Spearhead Insurance Solutions IDF, LLC, ADAR1 Capital Management, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, ADAR1 SPV I, LP and Spearhead Insurance Solutions IDF, LLC. As the general partner of ADAR1 Partners, LP and ADAR1 SPV I, LP, ADAR1 Capital Management GP, LLC may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP and ADAR1 SPV I, LP. As the manager of ADAR1 Capital Management, LLC and ADAR1 Capital Management GP, LLC, Mr. Schneeberger may be deemed to indirectly beneficially own securities held by ADAR1 Partners, LP, Spearhead Insurance Solutions IDF, LLC, and ADAR1 SPV I, LP.
- The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
- The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.21 to $9.56, inclusive.
- The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.13 to $10.60, inclusive.
- In connection with the purchase of 325,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 325,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 624,333 shares.
- In connection with the purchase of 500,000 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 500,000 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 124,333 shares.
- In connection with the purchase of 74,333 securities reported as being purchased in Table 1, ADAR1 Partners, LP and the counterparty to the cash-settled total equity swaps previously reported agreed to reduce the number of notional shares of Common Stock of the Issuer in the applicable basket by a corresponding number of 74,333 shares. As a result, the aggregate number of notional shares of Common Stock of the Issuer in the applicable basket after giving effect to such transactions is 50,000 shares.
- For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.